Application 219323

Type
ANDA
Sponsor
ALKEM LABS LTD

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001MIRABEGRONMIRABEGRONFOR SUSPENSION, EXTENDED RELEASE;ORAL8MG/MLNoNo

Documents

DocumentTitleSubmission typeSubmission no.DateStorage
849890ORIG 12026-02-11Cached in FDA.report object storage